Documenting a Thesis and Monitoring Triggers

Equicurious Teamintermediate2025-08-01Updated: 2026-03-21
Illustration for: Documenting a Thesis and Monitoring Triggers. Thesis documentation and trigger monitoring prevent emotional decision-making. L...

Most investors can tell you why they bought a stock. Almost none can show you the written record proving it. The result: positions drift from their original rationale, kill criteria never get defined (so losses compound unchecked), and quarterly reviews become exercises in retroactive justification rather than honest audits. General Electric shareholders who held from $31 to $7 between 2016 and 2018—a 77% decline—largely did so because they never wrote down the specific conditions that would force a sale (SEC EDGAR, GE 10-K filings 2016–2018). The fix is a thesis journal with pre-committed monitoring triggers that remove discretion at the moments you're least equipped to exercise it.

TL;DR: Write down exactly why you're buying, define 2–4 numeric kill criteria before you deploy capital, and audit every position quarterly against those original assumptions. The journal is the forcing function; the triggers are the discipline.

What a Thesis Journal Actually Contains (And Why Each Element Matters)

An investment thesis is a written, falsifiable statement explaining why a specific security is expected to generate a target return over a defined time horizon, supported by identified catalysts and quantified assumptions. The key word is falsifiable—if you can't specify what would prove you wrong, you don't have a thesis. You have a hope.

A thesis journal is the dated log that holds this work. Before purchasing any position, it should contain five elements:

  1. A 2–3 sentence thesis statement with a specific return expectation and time horizon (typically 12–36 months for fundamental equity positions)
  2. 3–5 quantified assumptions (e.g., revenue growth of 12%, ROIC above 14%, forward P/E below 18x)
  3. Expected holding period with a catalyst timeline
  4. Target price with the valuation method used to derive it
  5. 2–4 specific kill criteria with numeric thresholds

The point is: this documentation must be completed before any capital is deployed. No exceptions. Writing it afterward defeats the purpose—your memory will already be contaminated by the price action.

A monitoring trigger is a pre-specified quantitative or qualitative condition that, when breached, compels you to re-evaluate or exit. Examples include a 20% year-over-year revenue decline for two consecutive quarters or the loss of a key customer representing more than 15% of sales. These aren't suggestions. They're commitments.

Thesis documentation → Quantified assumptions → Pre-set triggers → Forced review → Disciplined exit or reaffirmation

Why this matters: without this chain, you get thesis drift—the gradual, undocumented shift where original buy reasons no longer apply but new justifications get substituted without formal re-evaluation. Thesis drift is how a "growth at a reasonable price" position quietly becomes a "deep value turnaround" position without anyone making a conscious decision.

How to Set Triggers That Actually Work (Calibrating Thresholds)

Triggers need to be specific enough to fire and broad enough to avoid constant false alarms. The research points to five categories with tested thresholds:

Margin Deterioration

A gross margin decline of more than 500 basis points (5 percentage points) from the level at thesis initiation warrants mandatory review. Intel's gross margin fell from 56% in 2020 to approximately 40% by 2023 (SEC EDGAR, Intel 10-K filings 2020–2023). Investors with a trigger set at below 50% would have reassessed by mid-2021—well before the worst of the decline.

Revenue Growth Miss

Two consecutive quarters of revenue growth more than 10 percentage points below your thesis assumption signals that the core growth story is breaking. This isn't about one bad quarter (cyclicality happens). It's about sustained divergence from documented expectations.

Debt Leverage Ceiling

Net debt-to-EBITDA exceeding 4x for non-financial companies (or 2x above the level documented at entry) triggers review. Valeant Pharmaceuticals saw debt-to-EBITDA exceed 7x before its 90% decline from $257 to $27 between August 2015 and April 2016 (SEC EDGAR, Valeant 10-K/8-K filings 2015–2016). Documented kill criteria around leverage above 5x would have triggered an exit before the worst losses.

Valuation Ceiling

Forward P/E exceeding 1.5x the stock's 5-year average multiple signals an overvaluation review. For context: the S&P 500 trailing P/E as of February 2026 sits at 28.25x against a long-term median of 15.9x (1871–2025, Multpl/Shiller data) and a 5-year average of 22.74x. These benchmarks help you calibrate whether your individual stock's multiple expansion is justified or euphoric.

Catalyst Timeline Expiry

If your primary catalyst has not materialized within 6 months past the originally documented expected date, initiate an exit review. Capital has an opportunity cost. A thesis without a working catalyst is dead capital.

The point is: you set these thresholds once, at entry, when you're thinking clearly. You don't renegotiate them when a position is down 30% and your judgment is compromised.

Worked Example: Documenting a Consumer Cyclicals Thesis

Here's what a complete thesis journal entry looks like in practice, using real sector data.

Phase 1: The Setup (Entry Documentation)

You identify a mid-cap consumer cyclicals company trading at 18x forward P/E (your sample valuation multiple). The S&P 500 consumer cyclicals sector shows an ROIC of 10.7% and a NOPAT margin of 8.3% (New Constructs, 1Q 2024). Your target company reports 14% ROIC—meaningfully above the sector median, suggesting a competitive advantage.

Thesis journal entry (dated):

FieldEntry
ThesisCompany X's above-sector ROIC (14% vs. 10.7% sector median) reflects pricing power in its niche. At 18x forward P/E, shares are priced below the S&P 500's 5-year average of 22.74x. Expect 15–20% return over 18 months as the market re-rates toward sector peers.
Key assumptions(1) Revenue growth ≥ 8% annually, (2) ROIC stays above 12%, (3) Forward P/E remains below 22x, (4) NOPAT margin holds above 7%, (5) Net debt-to-EBITDA stays below 3x
Holding period12–18 months
Target price22x forward earnings = 22 × current EPS estimate (derived from spreadsheet valuation model)
CatalystNew product line launching Q3 2026, expected to add 3–4% to revenue growth
Kill criteria(1) ROIC falls below 10%, (2) Revenue growth misses by >10 pp for two consecutive quarters, (3) Top customer exceeds 15% of revenue or any >10% customer is lost, (4) Gross margin declines >500 bps from entry level

You verify the company's financials using SEC EDGAR (free public access to 10-K, 10-Q, and 8-K filings) and cross-reference fund holdings and ratings through Morningstar fund research for independent validation.

Phase 2: The Quarterly Audit (90-Day Review)

Three months in, you pull the latest 10-Q (filed within 40 days of quarter-end for large accelerated filers) and score each assumption:

AssumptionStatusCurrent Data
Revenue growth ≥ 8%Intact9.2% YoY
ROIC above 12%Intact13.5%
Forward P/E below 22xIntact19.1x
NOPAT margin above 7%Weakened7.4% (down from 8.3% at entry)
Net debt-to-EBITDA below 3xIntact2.1x

One assumption weakened, four intact. No action required—but you log the margin compression and set a tighter watch. You note the specific 10-Q line items where you found the data (this prevents future "I think the margin was fine" memory distortions).

Phase 3: The Trigger Event (What Forced Discipline Looks Like)

Six months in, the 10-Q reveals NOPAT margin has dropped to 6.1%—below your 7% threshold—and ROIC has fallen to 11.2%. Two assumptions now score as broken (margin and approaching ROIC threshold). The Q3 product launch catalyst has been delayed to Q1 2027.

Per your documented rules: two or more broken assumptions trigger a 5-business-day exit review. Catalyst timeline expiry (6 months past expected date) would trigger independently by Q1 2027.

You conduct the written re-evaluation. You either document a refreshed thesis with updated numbers and new kill criteria, or you begin an orderly exit within 10 trading days.

The practical point: Without the journal, you'd likely hold through this deterioration, telling yourself "it'll bounce back" or "the product launch is just delayed." The documentation removes the option of self-deception. The trigger fires; you respond.

Mechanical alternative: Set automated price alerts at 15% and 25% below your cost basis as a drawdown backstop. When the 15% alert fires, re-read your original thesis entry. When the 25% alert fires, conduct the full written re-evaluation or exit.

Three Thesis Failures That Triggers Would Have Caught

The historical record is clear on what undisciplined thesis management costs:

General Electric (2016–2018): Operating margins contracted from 12.5% to below 5%. The dividend was cut from $0.24/quarter to $0.01/quarter. A margin trigger at 8% would have forced review years before the $31-to-$7 collapse (SEC EDGAR, GE 10-K filings).

Valeant Pharmaceuticals (2015–2016): A 90% decline ($257 to $27). Debt-to-EBITDA exceeded 7x. A leverage trigger at 5x would have prompted exit before catastrophic losses materialized (SEC EDGAR, Valeant 10-K/8-K filings).

Intel (2020–2023): Data-center CPU market share dropped from approximately 90% to below 70%. ROIC fell from approximately 15% to below 5%. A gross-margin trigger at 50% (set against the 56% entry level) would have flagged the deterioration by mid-2021 (SEC EDGAR, Intel 10-K filings; Mercury Research).

What experience teaches: in every case, the fundamental deterioration was visible in the filings quarters before the worst price declines. The problem was never information—it was the absence of pre-committed rules that forced action on that information.

Detection Signals (Are You Drifting?)

You're likely experiencing thesis drift if:

  • You can describe why you bought a stock but can't point to a written record with specific numbers
  • Your current rationale for holding differs from your original reason for buying (and you never formally documented the change)
  • You find yourself saying "it's a long-term hold" for a position whose original thesis had a 12–18 month horizon
  • You check the price daily but haven't read the last two 10-Q filings
  • You've mentally moved your "I'd sell if it hits X" number three or more times without writing down why

The test: pull up any position in your portfolio right now. Can you state, from a written record, the exact conditions under which you committed to sell? If not, you're operating without triggers.

Thesis Documentation Checklist

Essential (high ROI)—prevents 80% of undisciplined exits and holds:

  • Write a dated thesis journal entry before every purchase (thesis statement, 3–5 quantified assumptions, holding period, target price, 2–4 kill criteria)
  • Set price alerts at 15% and 25% below cost basis for every position
  • Schedule quarterly thesis audits (every 90 days) on your calendar with a recurring reminder
  • Score each assumption as intact, weakened, or broken—initiate exit review when 50% or more score as broken

High-impact (workflow and automation):

  • Bookmark SEC EDGAR for each holding's CIK number (10-K due within 60 days, 10-Q within 40 days of period-end)
  • Cross-reference thesis assumptions against Morningstar independent ratings and style-box classifications
  • Log all trigger events and review outcomes in the thesis journal (creating an auditable decision trail)

Optional (good for concentrated portfolios with 10 or fewer positions):

  • Track customer concentration risk quarterly (flag any single customer exceeding 10–15% of revenue, per SEC disclosure requirements)
  • Monitor catalyst timelines and flag any 6-month-past-expected-date expiry for exit review
  • Compare each holding's current multiple against its own 5-year average (flag at 1.5x that average)

Your Next Step

Open a spreadsheet or document right now. Pick one position in your portfolio—your largest holding works best. Write a thesis journal entry using the five-field template from the worked example above (thesis statement, key assumptions, holding period, target price, kill criteria). Then check the company's most recent 10-Q on SEC EDGAR and score each assumption. This single exercise, taking roughly 30 minutes, will reveal whether you actually have a thesis—or whether you've been holding on memory and hope. For building the valuation model that feeds your target price, see Building a Simple Valuation Model in a Spreadsheet.

Related Articles